Crossmark

Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis

Published Online: 2019-05-10

Published Print: 2019-07

Authors

Zhong, Fudi

Hu, Zhigao

Jiang, Keqing

Lei, Biao

Wu, Zhan

Yuan, Guandou

Luo, Hongliang

Dong, Chunqiang

Tang, Bo

Zheng, Chaowen

Yang, Shuai

Zeng, Yonglian

Guo, Zhenya

Yu, Shuiping

Su, Huizhao

Zhang, Guo

Qiu, Xiaoqiang

Tomlinson, Stephen

He, Songqing
License Information

Text and Data Mining valid from 2019-05-10

Version of Record valid from 2019-05-10
More Information

Article History

Received: 1 September 2018

Accepted: 12 April 2019

First Online: 10 May 2019

Competing interests

: Stephen Tomlinson is an inventor on a licensed patent for CR2-targeted complement inhibition. The other authors declare no competing interests.

Document is current